Search Results - Yuichiro Eguchi
- Showing 1 - 20 results of 39
- Go to Next Page
-
1
The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment by Toshihiko Mizuta, Iwata Ozaki, Yuichiro Eguchi, Tsutomu Yasutake, Seiji Kawazoe, Kazuma Fujimoto, Kyosuke Yamamoto
Published 2006Artigo -
2
Effects of home‐based exercise and branched‐chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis by Yuichiro Nishida, Yasushi Ide, Michiaki Okada, Taiga Otsuka, Yuichiro Eguchi, Iwata Ozaki, Keitaro Tanaka, Toshihiko Mizuta
Published 2016Artigo -
3
-
4
Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma by Hao Zhang, Iwata Ozaki, Toshihiko Mizuta, Hiroshi Hamajima, Tsutomu Yasutake, Yuichiro Eguchi, H Ideguchi, Kyosuke Yamamoto, Shinpei Matsuhashi
Published 2006Artigo -
5
-
6
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods by Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuji Ogawa, Yuichiro Eguchi, Yoshio Sumida, Masashi Yoneda, Miwa Kawanaka, Satoru Saito, Katsutoshi Tokushige, Atsushi Nakajima
Published 2017Revisão -
7
Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis by Motoyasu Kojima, Hirokazu Takahashi, Takuya Kuwashiro, Kenichi Tanaka, Hitoe Mori, Iwata Ozaki, Yoichiro Kitajima, Yayoi Matsuda, Kenji Ashida, Yuichiro Eguchi, Keizo Anzai
Published 2020Artigo -
8
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty live... by Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda, Kento Imajo, Nobuharu Tamaki, Hideki Suganami, Toshiaki Nojima, Ryohei Tanigawa, Masakazu Iizuka, Yuki Iida, Rohit Loomba
Published 2021Artigo -
9
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients by Kazuhiro Takahashi, Toshihiko Mizuta, Seiji Kawazoe, Yuichiro Eguchi, Yasunori Kawaguchi, Taiga Otuka, Satoshi Oeda, Keisuke Ario, Shinji Iwane, Takumi Akiyama, Iwata Ozaki, Kazuma Fujimoto
Published 2010Artigo -
10
Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia by Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova
Published 2019Revisão -
11
Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case‐control study in Japan by Keitaro Tanaka, Megumi Hara, Tatsuhiko Sakamoto, Yasuki Higaki, Toshihiko Mizuta, Yuichiro Eguchi, Tsutomu Yasutake, Iwata Ozaki, Kyosuke Yamamoto, Shingo Onohara, Seiji Kawazoe, Hirohisa Shigematsu, Shunzo Koizumi
Published 2006Artigo -
12
-
13
Influence of alcohol consumption and gene polymorphisms of<i>ADH2</i>and<i>ALDH2</i>on hepatocellular carcinoma in a Japanese population by Tatsuhiko Sakamoto, Megumi Hara, Yasuki Higaki, Masayoshi Ichiba, Mikako Horita, Toshihiko Mizuta, Yuichiro Eguchi, Tsutomu Yasutake, Iwata Ozaki, Kyosuke Yamamoto, Shingo Onohara, Seiji Kawazoe, Hirohisa Shigematsu, Shunzo Koizumi, Keitaro Tanaka
Published 2005Artigo -
14
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism by Rina Komazaki, Sayaka Katagiri, Hirokazu Takahashi, Shogo Maekawa, Takahiko Shiba, Yasuo Takeuchi, Yoichiro Kitajima, Anri Ohtsu, S. Udagawa, Naoki Sasaki, Kazuki Watanabe, Noriko Sato, Naoyuki Miyasaka, Yuichiro Eguchi, Keizo Anzai, Yuichi Izumi
Published 2017Artigo -
15
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoho... by Sakura Yamamura, Dan Nakano, Ryuki Hashida, Tsubasa Tsutsumi, Takumi Kawaguchi, Michiaki Okada, Hiroshi Isoda, Hirokazu Takahashi, Hiroo Matsuse, Yuichiro Eguchi, Yoshio Sumida, Atsushi Nakajima, Lynn H. Gerber, Zobair M. Younossi, Takuji Torimura
Published 2020Revisão -
16
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population by Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue
Published 2012Artigo -
17
LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicent... by Kento Imajo, Hideyuki Hyogo, Masato Yoneda, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Yuji Ogawa, Masataka Taguri, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Hiroyuki Kirikoshi, Satoru Saito, Yoshio Sumida, Masafumi Ono, Koichiro Wada, Atsushi Nakajima, Yuichiro Eguchi
Published 2014Artigo -
18
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography by Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo, Yoshio Sumida, Masafumi Ono, Yuichiro Eguchi, Tomio Inoue, Takeharu Yamanaka, Koichiro Wada, Satoru Saito, Atsushi Nakajima
Published 2015Artigo -
19
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis by Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima
Published 2020Revisão -
20
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic by Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima
Published 2021Revisão
Search Tools:
Related Subjects
Medicine
Internal medicine
Gastroenterology
Disease
Fatty liver
Nonalcoholic fatty liver disease
Hepatocellular carcinoma
Biology
Steatohepatitis
Cirrhosis
Liver disease
Endocrinology
Diabetes mellitus
Fibrosis
Hepatology
Type 2 diabetes
Biochemistry
Gene
Surgery
Chronic liver disease
Environmental health
Insulin
Pathology
Population
Biopsy
Genetics
Genotype
Liver biopsy
Metabolic syndrome
Obesity